NewEdge Advisors’s Mural Oncology MURA Stock Holding History

NewEdge Advisors’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$10	–	4335
2025 Q3	$10	Hold	5	–	–	﹤0.01%	4078
2025 Q2	$12	Sell	5 -10	-67%	-$24	﹤0.01%	3967
2025 Q1	$19	Hold	15	–	–	﹤0.01%	3899
2024 Q4	$48	Buy	15 +10	+200%	+$35	﹤0.01%	3823
2024 Q3	$16	Hold	5	–	–	﹤0.01%	3775
2024 Q2	$16	Sell	5 -5	-50%	-$18	﹤0.01%	3743
2024 Q1	$48	Buy	10 +5	+100%	+$24	﹤0.01%	3734
2023 Q4	$30	Buy	+5	New	+$20	﹤0.01%	3688

NewEdge Advisors's MURA Position: Q4 2025 in Review

NewEdge Advisors sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 5 shares — an estimated $10 sold.

NewEdge Advisors first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $48 in Q4 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

NewEdge Advisors reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
NewEdge Advisors sold 5 Mural Oncology shares in Q4 2025, an estimated $10.
NewEdge Advisors first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
NewEdge Advisors's Mural Oncology position peaked at $48 in Q4 2024.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on NewEdge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.